English version
Nina Ånensen

Nina Ånensen

Administrative arbeidsområder

Avtaler om forskningssamarbeid   Cristin   EU   Finansiering   Forskningskvalitet   Forskningssamarbeid   Forskningsstrategi

Vitenskapelige publikasjoner

Ånensen, Nina; Hjelle, Sigrun Margrethe; Van, Belle Werner; Haaland, Ingvild; Silden, Elisabeth; Bourdon, Jean-Christophe; Hovland, Randi; Tasken, Kjetil; Knappskog, Stian; Lønning, Per Eystein; Bruserud, Øystein; Gjertsen, Bjørn Tore (2012). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene . Vol. 31.

Øyan, Anne Margrete; Ånensen, Nina; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer . Vol. 9.

Ånensen, Nina; Øyan, Anne Margrete; Huseby, Sjur; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy . Vol. 7.

Gjertsen, Bjørn Tore; Bredholt, Therese; Ånensen, Nina; Vintermyr, Olav (2007). Bcl-2 antisense in the treatment of human malignancies: A delusion in targeted therapy. Current Pharmaceutical Biotechnology . Vol. 8.

Irish, Jonathan C.; Ånensen, Nina; Hovland, Randi; Skavland, Jørn; Børresen-Dale, Anne-Lise; Bruserud, Øystein; Nolan, Gary P; Gjertsen, Bjørn Tore (2007). Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood . Vol. 109.

Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta; Ånensen, Nina; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein (2007). Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. European Journal of Haematology . Vol. 79.

Bruserud, Øystein; Stapnes, Camilla I; Tronstad, Karl Johan; Ryningen, Anita; Ånensen, Nina; Gjertsen, Bjørn Tore (2006). Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert opinion on therapeutic targets . Vol. 10.

Ånensen, Nina; Haaland, Ingvild; D Santos, Clive; Belle, Werner Van; Gjertsen, Bjørn Tore (2006). Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Current Pharmaceutical Biotechnology . Vol. 7.

Ånensen, Nina; Øyan, Anne Margrete; Bourdon, Jean-Christophe; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clinical Cancer Research . Vol. 12.

Van Belle, Werner; Sjøholt, Gry; Ånensen, Nina; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore (2006). Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment. Electrophoresis . Vol. 27.





Publikasjonslisten er hentet ut av Cristin. Listen kan være ufullstendig